Since the most recent ECDC rapid risk assessment in 2021, the number of EU/EEA countries reporting hypervirulent Klebsiella pneumoniae (hvKp) sequence type (ST) 23 has increased from four to ten and the number of cases reported to ECDC by the countries, increased from 12 to 143.
This document assesses the risk associated with the dissemination of carbapenemase-producing hypervirulent Klebsiella pneumoniae (hvKp) of sequence type (ST) 23 and other STs in the European Union/European Economic Area (EU/EEA).
From 29 January to 2 February 2024, a team of experts from EC, ECDC, EFSA, Epiconcept and the Integrated Quality Laboratory Services (IQLS) will visit North Macedonia.
The European Antimicrobial Resistance Genes Surveillance Network (EURGen-Net) is a surveillance network for genomic-based surveillance of multidrug-resistant bacteria of public health importance, coordinated by the European Centre for Disease Prevention and Control (ECDC).
Antimicrobial resistance is a major public health challenge in Europe and globally. Each year throughout the European Union (EU), Iceland and Norway, more than 35 000 people die from infections with bacteria that are resistant to antimicrobials.
The eighth ‘Exchange of Experts’ programme visit for public health experts from the European Neighbourhood Policy (ENP) partner countries took place on 28 and 29 November 2023 at the Public Health Agency of Sweden.
A joint study of the National Public Health Organization in Greece (NPHO) and the European Centre for Disease Prevention and Control (ECDC) conducted in 15 Greek hospitals in 2022 sheds light on the rapid spread of carbapenemase-producing, highly drug-resistant Klebsiella pneumoniae sequence type (ST) 39, following its initial documentation in a European-wide genomic survey in 2019.
The main aim of the genomic study described in this surveillance report was to determine the distribution of the highly drug-resistant clade of Klebsiella pneumoniae (sequence type (ST) 39 in Greek hospitals in 2022.
European Antibiotic Awareness Day (EAAD) is a European health initiative coordinated by ECDC. It provides a platform and support for national campaigns on the prudent use of antibiotics in the EU/EEA and take place each year across Europe on 18 November.
EARS-Net is based on routine clinical antimicrobial susceptibility data from local and clinical laboratories reported to ECDC by appointed representatives from the Member States.